These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1584446)

  • 1. [Value of the Pap-test in the cervical cytological screening].
    Giannone R; Piacezzi C; Poli M; Bernorio R
    Minerva Ginecol; 1992 Apr; 44(4):155-9. PubMed ID: 1584446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Pap test revisited].
    Broso P; Pagani E
    Minerva Ginecol; 1991 Mar; 43(3):71-85. PubMed ID: 2057106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytological history of 101 patients with invasive cancer of the uterine cervix].
    Vincenzoni C; Mariani L; Vocaturo G; Lombardi A; Iacovelli A
    Minerva Ginecol; 1991 Jun; 43(6):273-7. PubMed ID: 1922899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
    Magnus K; Langmark F
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1557-9. PubMed ID: 2187277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS; Gupta HP; Das V
    Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
    Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
    Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.
    Crocetti E; Battisti L; Betta A; Palma PD; Paci E; Piffer S; Pojer A; Polla E; Zappa M
    Eur J Cancer Prev; 2007 Dec; 16(6):564-7. PubMed ID: 18090131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The incidence of borderline and pathologic findings in young females within the scope of gynecologic-cytologic screening studies].
    Neumann HG; Barten G; Barten M; Schröder M
    Zentralbl Gynakol; 1989; 111(14):947-51. PubMed ID: 2800778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R; Khawaja NP; Malik N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of adenocarcinoma of the uterine cervix in mass cytological and colposcopic diagnostic studies].
    Pieroni G; Cariaggi P; Ottaviano M; Marchionni M; Mincione G; Bartoloni St Omer F
    Minerva Ginecol; 1975 May; 27(5):418-21. PubMed ID: 1134695
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of cytological screening for neoplasms in young women].
    Kubista E; Kucera H; Ulm R
    Osterr Z Onkol; 1976; 3(4):103-6. PubMed ID: 1037017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.